Results 171 to 180 of about 14,279 (236)

Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis. [PDF]

Aliment Pharmacol Ther
Schattenberg JM, Banales JM, Hirschfield G, Trivedi P, Cable EE, McWherter CA, Billin AN, Crittenden DB, Budas G.   +8 more
europepmc   +1 more source

Molecular Mechanisms and Clinical Evidence Supporting the Four Pillars of Therapy in Diabetic Kidney Disease: Emerging Therapeutic Perspectives. [PDF]

Int J Mol Sci
Yanai H, Adachi H, Hakoshima M, Katsuyama H.   +3 more
europepmc   +1 more source

Acute pancreatitis caused by severe hypertriglyceridemia in a 61-year-old man on a carnivore diet. [PDF]

CMAJ
Squire P, Ghosh M.
europepmc   +1 more source

Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational Study. [PDF]

J Cachexia Sarcopenia Muscle
Elahjji R, Blow T, Grover R, Hurd MA, Dunne RF, Caan BJ, Cespedes Feliciano EM, Plodkowski AJ, Flory JH, Goncalves MD.   +9 more
europepmc   +1 more source

Second-line therapies in PBC-related cirrhosis: balancing efficacy and safety. [PDF]

Hepatobiliary Surg Nutr
Rogalski P, Rogalska M.
europepmc   +1 more source

High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy. [PDF]

Hepatol Commun
Cançado GGL, Chen B, Cameron M, Houri I, Leung KK, Gulamhusein AF, Hansen B, Hirschfield GM.   +7 more
europepmc   +1 more source

Long-Term Adherence and Drug Utilisation Patterns Among New Users of Anti-Hyperlipidemic Monotherapy: Development of a Risk Prediction Model. [PDF]

J Eval Clin Pract
Li X, Hak E, Bos JHJ, Schuiling-Veninga CCM, Mubarik S.   +4 more
europepmc   +1 more source

Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis. [PDF]

Eur J Med Res
Zhang S, Sun T, Song L, Jin X, Li B.
europepmc   +1 more source